Skip to content

Effects of Wearable Robot-Assisted Gait Intervention on Patients with Hip Fractures

Effects of hip-assist wearable-robot on gait and balance in patients with hip joint fracture

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0010843
Enrollment
60
Registered
2025-08-05
Start date
2025-10-10
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Others : This study involves gait training using a wearable hip-assistive robot for patients who have undergone hip fracture surgery. Participants will be enrolled in the study for six

Sponsors

Baekseok University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients hospitalized for rehabilitation within 30 days after hip fracture surgery Patients who were able to walk independently before the surgery (assistive device allowed) Functional Ambulation Categories (FAC) score of 2 or higher No history of lower limb surgery or neurological disorders within the past 12 months Voluntary written consent obtained after receiving full explanation of the study

Exclusion criteria

Exclusion criteria: Severe cognitive impairment or language/perceptual deficits affecting command following Medical conditions (e.g., cardiovascular or respiratory) that limit gait training Patients instructed to maintain non-weight-bearing status Anatomical or functional limitations that prevent wearing the robot device

Design outcomes

Primary

MeasureTime frame
gait speed;step length;cadence;range of motion;muscle strength;walking time

Secondary

MeasureTime frame
berg balance scale;plantar pressure;timed up and go test;functional ambulation categories;Western Ontario and McMaster Universities index Korean version;visual analogue scale

Countries

Korea, Republic of

Contacts

Public ContactHoJin Choi

Baekseok University

gh9691@naver.com+82-41-550-9114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026